Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer.

Gianni, L; Dombernowsky, P; Sledge, G; Martin, M; Amadori, D; Arbuck, S G; Ravdin, P; Brown, M; Messina, M; Tuck, D; Weil, C; Winograd, B

Gianni, L; Dombernowsky, P; Sledge, G; Martin, M; Amadori, D; Arbuck, S G; Ravdin, P; Brown, M; Messina, M; Tuck, D; Weil, C; Winograd, B.

Affiliation

Gianni L; Unit of Medical Oncology A, Istituto Nazionale Tumori, Milan, Italy. gianni@istitutotumori.mi.it

Ann Oncol ; 12(8): 1067-73, 2001 Aug.

Article in En | MEDLINE | ID: mdl-11583187

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/drug therapy; Heart Failure/chemically induced; Adult; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/physiopathology; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Female; Humans; Paclitaxel/administration & dosage; Paclitaxel/adverse effects; Retrospective Studies; Stroke Volume/drug effects; Ventricular Function, Left/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Heart Failure Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Ann Oncol Year: 2001 Document type: Article

Search on Google

XML

PubMed Links